DR. EDWARD FUTCHER - Corporate Board Profile

VOLITIONRX LTD

Filing Date	Source Excerpt
2016-08-22	DR. EDWARD FUTCHER serves as a director. Dr. Futcher holds a B.Sc. in Physics and a Ph.D. in Physics from the University of London and has extensive experience in engineering and management in high technology companies. Since 1997, Dr. Futcher has held non-executive directorships with a variety of private companies. He co-founded Azima, Inc. in 2003, a company that provides advanced machine diagnosis to large industrial facilities and, from 2003 to 2008, served as its Vice President of Engineering with responsibility for the engineering, information technology and customer support groups. Prior to that, from 1997 to 2003, Dr. Futcher served as Vice President of Technology of interWAVE Communications International, Ltd., a company providing GSM and CDMA cellular infrastructure equipment, where he was responsible for operational management of acquisitions and interim management of the worldwide research and development organization. From 1997 to 1999, Dr. Futcher also served as Vice President of Engineering of interWAVE Communications. From 1994 to 1997, Dr. Futcher was Director of Engineering at Tellabs, Inc., a telecommunications equipment supplier. The board of directors believes that Dr. Futcher is qualified to serve as a director of the Company based on his extensive commercial and management experience in dynamic and fast growing companies.
2017-07-24	DR. EDWARD FUTCHER serves as a director. Information regarding Dr. Futcher is provided under Proposal 1 – Election of Directors starting on page 27 of this Proxy Statement.
2018-07-20	DR. EDWARD FUTCHER serves as a Director. ... The Board of Directors believes that Dr. Futcher is qualified to serve as a Director of the Company based on his extensive commercial and management experience in dynamic and fast growing companies.
2019-04-29	Our Audit Committee consists of four members, Mr. Innes (Chair), and Drs. Skaff, Colman and Futcher, each of whom has been determined to be an independent director under applicable SEC rules and the applicable rules of the NYSE American. ... Our Compensation Committee consists of three members, Mr. Innes (Chair) and Drs. Skaff and Futcher, each of whom has been determined to be an independent director under the applicable rules of the NYSE American. ... Our Nominations and Governance Committee consists of three members, Mr. Innes (Chair) and Drs. Skaff and Futcher, each of whom has been determined to be an independent director under the applicable rules of the NYSE American.
2020-04-29	DR. EDWARD FUTCHER serves as a director. ... Our board of directors believes that Dr. Futcher is qualified to serve as a director of the Company based on his extensive commercial and management experience in dynamic and fast growing companies.
2021-04-29	DR. EDWARD FUTCHER serves as a director. Information regarding Dr. Futcher is provided under the Proposal 1 – Election of Directors section of this Proxy Statement.
2022-04-28	DR. EDWARD FUTCHER serves as a director. ... Our board of directors believes that Dr. Futcher is qualified to serve as a director of the Company based on his extensive commercial and management experience in dynamic and fast growing companies, and his ability to provide strategic counsel in connection with the commercialization of the Nu.Q blood-based diagnostic platform.
2023-04-28	Dr. Edward Futcher serves as a director. ... Dr. Futcher is a member of the Audit Committee and Nominations and Governance Committee. ... Compensation of Directors Table shows Dr. Futcher received total compensation of $63,136 for the fiscal year ended December 31, 2022.